NEULIVE MEDICAL

NEULIVE MEDICAL is a medical technology company based in China with a global outlook. The company has a comprehensive layout across the six major disease areas of neuroscience, focusing on the two main lines of neurointervention and neuromodulation. It is committed to providing patients with comprehensive and high-quality overall solutions for neurointervention and neuromodulation. The diseases treated cover hemorrhagic and ischemic stroke, pain, epilepsy, Parkinson's disease, obsessive-compulsive disorder, and more. Among many China-based companies, NEULIVE MEDICAL has broken through the competition to establish a highly competitive proprietary product system, relying on its team’s top-tier original research capabilities and globally leading core technologies and craftsmanship. Since its establishment, the team has made comprehensive arrangements and multi-point developments in the field of neurointervention and neuromodulation. With unique innovative products, it has avoided homogenized competition traps. Multiple products have entered clinical trials, and several product technologies are expected to be globally leading, filling the gap for China-produced products. It is the first company in China to comprehensively cover the neuroscience track and truly achieve breakthroughs in technical barriers.